A new diagnostic test can detect the presence of prostate cancer in less than 15 minutes with an accuracy rate of up to 90%, according to researchers from Aston University in Birmingham, UK.

The researchers utilized a new technique that analyzes the composition of proteins found in dried blood, which, they claim, makes it easier to identify the presence of cancer.

In contrast to the currently dominant method for prostate cancer screening, the new technique is described as non-invasive and more accurate.

Professor Igor Meglinski, a member of the research team from Aston University, stated that the new technique "opens up new avenues for cancer diagnosis, marking a significant leap towards personalized pharmacology and oncology."

The study detailing the research was published in the journal *Scientific Reports*.

The research team analyzed dried blood samples from 108 men, including healthy volunteers and prostate cancer patients. It was found that in cancer carriers, the proteins change their three-dimensional shape as they aggregate in the early stages of the disease.